Clinical Trials Directory

Trials / Unknown

UnknownNCT04905875

Prone Positioning for Invasively Ventilated Patients With COVID-19 Registry

Prone Positioning for Invasively Ventilated Patients With COVID-19: an Interactive, Web-based, Multicenter, Observational Registry

Status
Unknown
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
St. Bortolo Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

SARS-CoV-2 infection is characterized mainly by moderate/severe pneumonia associated with progressive endothelial damage and coagulopathy. Acute respiratory failure among COVID-19 occurs in 42% of patients with COVID-19 pneumonia, and 61-81% of patients requiring intensive care . Among the suggested treatments for the management of ARDS patients, prone position (PP) can be used as an adjuvant therapy for improving ventilation in these patients, as recommended in the Surviving Sepsis Campaign COVID-19 guidelines. Nevertheless, no data is currently available on application and feasibility of PP in invasively ventilated patients with COVID-19 on their outcomes.

Conditions

Interventions

TypeNameDescription
PROCEDUREProne PositionEvery center will prescribe PP in accordance with local practice and local levels of expertise. No variation in treatment prescription and/or treatment solutions will derive from participation in this prospective observational study. Nonetheless, every setting parameter will be recorded in the web-based registry and analyzed a-posteriori to reveal a potential correlation with the patient outcomes.

Timeline

Start date
2020-12-01
Primary completion
2022-05-01
Completion
2022-05-01
First posted
2021-05-28
Last updated
2021-06-01

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04905875. Inclusion in this directory is not an endorsement.